Stephen Jarantow
Impact in
-
- Cancer Cells and Metastasis
- HER2/EGFR in Cancer Research
- CAR-T cell therapy research
-
- Monoclonal and Polyclonal Antibodies Research
Papers in
-
- Glycosylation and Glycoproteins Research 2
- Protein purification and stability 1
- Oncology 4
- HER2/EGFR in Cancer Research 3
- Co-authors
- José R. Pardinas (4 shared papers)Mark L. Chiu (5 shared papers)Sheri L. Moores (3 shared papers)Brandy Strake (1 shared paper)Robert A. Perkinson (2 shared papers)David C. Colter (1 shared paper)Kjell Johnson (1 shared paper)Jason E. Ekert (1 shared paper)
- Journals
- mAbs (2 papers)Diabetes (1 paper)PLoS ONE (1 paper)Journal of Biological Chemistry (1 paper)Cancer Research (1 paper)
- Partner nations
- United StatesBelgiumSwitzerland
In The Last Decade
Stephen Jarantow
7 papers receiving 339 citations
Peers
Comparison fields: 5 of 86
- Oncology 162
- Radiology, Nuclear Medicine and Imaging 85
- Cancer Research 37
- Pulmonary and Respiratory Medicine 67
- Hepatology 15
Countries citing papers authored by Stephen Jarantow
This map shows the geographic impact of Stephen Jarantow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen Jarantow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen Jarantow more than expected).
Fields of papers citing papers by Stephen Jarantow
This network shows the impact of papers produced by Stephen Jarantow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen Jarantow. The network helps show where Stephen Jarantow may publish in the future.
Co-authors
The 25 scholars most cited alongside Stephen Jarantow, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 131 | |
| 2 | 2016 | 77 | |
| 3 | 2023 | 47 | |
| 4 | 2015 | 47 | |
| 5 | 2016 | 40 | |
| 6 | 2016 | 12 | |
| 7 | 2022 | 1 |
About Stephen Jarantow
Stephen Jarantow is a scholar working on Molecular Biology, Oncology, Radiology, Nuclear Medicine and Imaging, Surgery and Pulmonary and Respiratory Medicine, having authored 7 papers that have together received 355 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (3 papers), HER2/EGFR in Cancer Research (3 papers), Glycosylation and Glycoproteins Research (2 papers), Protein purification and stability (1 paper), Prostate Cancer Treatment and Research (1 paper), Ferroptosis and cancer prognosis (1 paper), Liver physiology and pathology (1 paper) and Statistical Methods in Clinical Trials (1 paper). The work is most often cited by research in Oncology (162 citations), Radiology, Nuclear Medicine and Imaging (85 citations), Cancer Research (37 citations), Pulmonary and Respiratory Medicine (67 citations) and Hepatology (15 citations). Stephen Jarantow has collaborated with scholars based in United States, Belgium and Switzerland. Frequent co-authors include José R. Pardinas, Mark L. Chiu, Sheri L. Moores, Brandy Strake, Robert A. Perkinson, David C. Colter, Kjell Johnson, Jason E. Ekert, Barbara S. Bushey and Katharine D. Grugan. Their work appears in journals such as mAbs, Diabetes, PLoS ONE, Journal of Biological Chemistry and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.